Patient Data. Exhibits Review history, nurses' notes, and prescriptions. Which other medications might be helpful for this client in his management of asthma? Select all that apply.

Rationale: A. Glucocorticoids: Inhaled or systemic corticosteroids reduce airway inflammation and prevent exacerbations in asthma. They are an important part of long-term management, complementing rescue inhalers by addressing the underlying inflammatory process. B. Angiotensin-converting enzyme (ACE) inhibitor: ACE inhibitors are antihypertensives, not asthma treatments. They may actually worsen respiratory symptoms by inducing cough, making them inappropriate for asthma management. C. Loop diuretic: Loop diuretics are used to manage fluid overload and heart failure. They do not improve airway inflammation or bronchospasm, so they have no role in asthma treatment. D. Long-acting beta agonists: LABAs provide prolonged bronchodilation and are effective for long-term control when combined with inhaled corticosteroids. They help reduce the frequency of exacerbations but are not used as rescue medications. E. Antiproliferative agents: These medications are used in cancer treatment or transplant immunosuppression. They do not target asthma’s inflammatory or bronchospastic mechanisms. F. Biologics: Biologic therapies such as monoclonal antibodies (e.g., omalizumab, mepolizumab) target specific immune pathways in severe or allergic asthma. They can reduce exacerbation frequency and improve long-term control in clients with poorly controlled asthma despite standard therapies.